 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
International News India: WHO Approves 18th Ranbaxy HIV DrugAugust 5, 2008 On Friday, India's Ranbaxy Laboratories Ltd. announced the World Health Organization had approved its version of abacavir. The approval brings to 18 the number of Ranbaxy-manufactured antiretrovirals on WHO's prequalification list. Agencies like UNAIDS and UNICEF rely on WHO's list of prequalified drugs when making procurement decisions. Ranbaxy has promised to cooperate fully in an investigation by the U.S. government that began after the Food and Drug Administration warned the company in 2006 about manufacturing violations it found at a plant in India. Associated Press 8.01.2008  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
